Arena Pharma (ARNA) Misses Q3 EPS by 19c

Arena Pharma (NASDAQ: ARNA) reported Q3 EPS of ($0.86), $0.19 worse than the analyst estimate of ($0.67). Revenue for the quarter came in at $7.9 million versus the consensus estimate of $5.48 million.

For earnings history and earnings-related data on Arena Pharma (ARNA) click here.

You May Also Be Interested In

• TJX stock drops as profit outlook falls short of analyst estimates
• Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
• VNET Group (VNET) Misses Q2 EPS by 164c